Doctor profile · Federal record

Dr. Muffaddal Morkas, MD

Hematology & Oncology Physician (CMS: Medical Oncology) · Specialist · Houston, TX

  • NPI 1235168808
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 31 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
925 Gessner RD Ste 310
Houston, TX 770242546
(713) 467-1630
fax (713) 467-2256
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
April 10, 2018
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #M7447
Medicaid (2)
TX #212869602 · TX #212869603

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1235168808. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
28,353
Distinct HCPCS
10
Medicare allowed
$179,225
HCPCS Description Services Patients Avg allowed
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 8,630 16 $3
J1756 Injection, iron sucrose, 1 mg 8,100 20 $0
J1453 Injection, fosaprepitant, 1 mg 7,050 21 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 820 31 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 722 225 $8
J2469 Injection, palonosetron hcl, 25 mcg 620 27 $1
36415 Insertion of needle into vein for collection of blood sample 493 173 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 355 206 $92
99214 Established patient office or other outpatient visit, 30-39 minutes 264 123 $129
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 173 38 $29

In context: peer comparison

Among 79 peers in this city , average services per provider: 1,097. This provider delivers 26× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$947
Transactions
32
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 5 $175.23
Novartis Pharmaceuticals Corporation 4 $101.24
PFIZER INC. 4 $78.21
Karyopharm Therapeutics Inc. 3 $66.37
Celgene Corporation 2 $55.83
BeiGene USA, Inc. 2 $55.02
Incyte Corporation 2 $48.07
ABBVIE INC. 2 $47.98
Immunocore Limited 1 $32.67
Stemline Therapeutics Inc. 1 $30.75
GENZYME CORPORATION 1 $28.70
Rigel Pharmaceuticals, Inc. 1 $28.32
Astellas Pharma US Inc 2 $27.46
Daiichi Sankyo Inc. 1 $27.14
ADC Therapeutics America, Inc. 1 $26.05

By nature of payment

Food and Beverage
$848
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
655
Patients
152
Total drug cost
$1,569,622
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 98 21 $89,244
Anastrozole Generic 67 20 $1,862
Dexamethasone Generic 58 22 $1,218
Xarelto (Rivaroxaban) Brand 56 19 $61,504
Acyclovir Generic 53 0 $627
Duloxetine Hcl Generic 44 15 $927
Jakafi (Ruxolitinib Phosphate) Brand 41 0 $462,664
Levothyroxine Sodium Generic 36 16 $435
Levofloxacin Generic 35 22 $309
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 34 17 $928

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Muffaddal Morkas's medical specialty?
Dr. Muffaddal Morkas practices Hematology & Oncology Physician in Houston, TX.
Where does Dr. Muffaddal Morkas practice?
Dr. Muffaddal Morkas practices at 925 Gessner RD Ste 310, Houston, TX 770242546. Office phone: 7134671630.
What is Dr. Muffaddal Morkas's NPI?
Dr. Muffaddal Morkas's National Provider Identifier (NPI) is 1235168808, issued by NPPES.
Does Dr. Muffaddal Morkas accept Medicare assignment?
Yes. Dr. Muffaddal Morkas accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Muffaddal Morkas commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.